Craft

Apricus Biosciences

Stock Price

$0.2

2019-01-23

Market Capitalization

$6.2 M

2019-01-23

Revenue

$375 K

FY, 2019

Apricus Biosciences Summary

Company Summary

Overview
Apricus Biosciences is a biopharmaceutical company which focuses on the development and commercialization of product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The Company also engages in developing other medicines to treat rheumatoid and urological disease. The Company merged with Seelos Therapeutics.
Type
Public
Status
Closed
Founded
1987
HQ
San Diego, CA, US | view all locations
Website
http://www.apricusbio.com/
Cybersecurity rating
Sectors

Key People

  • Richard Pascoe

    Richard Pascoe, CEO

    • Brian Dorsey

      Brian Dorsey, Senior Vice President, Chief Development Officer

      • Neil Morton

        Neil Morton, Senior Vice President, Chief Business Officer

        • Mary Naggs

          Mary Naggs, Vice President, General Counsel

          LocationsView all

          1 location detected

          • San Diego, CA HQ

            United States

            11975 El Camino Real #300

          Apricus Biosciences Financials

          Summary Financials

          Net income (Q3, 2022)
          ($19.6M)
          Cash (Q3, 2022)
          $30.5M
          EBIT (Q3, 2022)
          ($17.4M)

          Footer menu